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ATRIAL NATRIURETIC 
PEPTIDE REPLACEMENT 
THERAPY IN RATS 
SUBJECTED TO BIATRIAL 
APPENDECTOMY 
The postoperative fluid retention found in some patients after the Cox maze 
procedure has been attributed to surgically induced loss of atrial natriuretic peptide. 
We postulated that exogenous atrial natriuretic peptide could reverse this antidi- 
uresis. A rat model was used to investigate this hypothesis. In group I, the sham 
group, the atrial appendages were left intact and the animals were then subjected to 
a fluid challenge equivalent to 1% of the animal's body weight. In group II, after 
biatrial appendectomy, the animals were subjected to a fluid challenge similar to 
that in group I. Animals in group III underwent he same protocol as that for group 
II plus intravenous administration of atriopeptin III at varying concentrations. 
Urine output and plasma atrial natriuretic peptide levels were significantly de- 
creased after biatrial appendectomies (p -< 0.01). Urine output returned to control 
levels after biatrial appendectomies with low-dose atrial natriuretic peptide infusion 
(0.5 pmol/min = 25.5 pg/min), although circulating atrial natriuretic peptide levels 
were lower. Urine output and plasma atrial natriuretic peptide levels increased with 
atrial natriuretic peptide infusions between 0.5 and 50 pmol/min. Heart rate and 
mean blood pressure did not vary significantly with atrial natriuretic peptide 
infusions. Thus atrial natriuretic peptide can be used effectively in low doses to 
induce a diuresis after biatrial appendectomies. Atrial natriuretic peptide may have 
clinical app|ication after the Cox maze procedure. (J T~IORAC CARDIOVASC SURG 
1995;109:976-80) 
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A mong the reported complications of the Cox maze procedure is postoperative fluid feten- 
tion in some patients that necessitates the use of 
osmotic diuretics followed by administration of 
spirolactone.1, 2 Although the mechanism for fluid 
retention is not known, a blunting of the pro- 
duction of the atrial natriuretic peptide (ANP) 
has been proposed as a partial explanation. 1 ANP, 
found in all mammalian species, has natriuretic, 
diuretic, and vasoactive properties as its principal 
effects.3, 4 This hormone, stored in granules in 
specialized atrial cells called cardiocytes, are most 
abundant in the right atrium and in the atrial 
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appendages. 3-6Prior studies have demonstrated 
that the loss of the right atrial appendage during 
heart operations can influence postoperative fluid 
retention », 7; biatrial appendectomies are done as 
part of the Cox maze procedure. 1 
ANP has been administered in therapeutie doses 
in animals, TM in normal human subjects, 12-aa nd in 
patients with congestive heart failure 1»' 19,20 and 
resulted in increased diuresis. Previous studies 
in human subjects, 5'21 rats,22-2e and dogs zS' 26 have 
indicated that either biatrial or right atrial appen- 
dectomy blunted diuresis and natriuresis nresponse 
to induced hypervolemia. Our hypothesis was that 
exogenous ANP (atriopeptin III; Peninsula, Bel- 
mont, Calif.), administered in replacement doses, 
could be used to replenish the circulating hormone 
and achieve adequate diuresis after biatrial appen- 
dectomies. 
Methods 
Experimental preparation. Adult male Sprague-Daw- 
ley rats with body weights between 375 and 400 gm 
underwent one of three surgical procedures. All animals 
received humane care in compliance with the "Principles 
of Laboratory Animal Care" formulated by the National 
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Society for Medical Research, the "Guide for the Care 
and Use of Laboratory Animals" prepared by the Na- 
tional Academy of Sciences and published by the National 
Institutes of Health, and the Veterinary Division of Mon- 
tefiore Medical Center. All animals received rat chow ad 
libitum that contained 0.11 and 0.23 mEq per gram of 
sodium and potassium, respectively. Tap water was avail- 
able to the animals ad libitum. The rats were anesthetized 
with sodium pentobarbital (60 mg/kg intraperitoneally) 22 
and were placed on a surgical tray over a heating pad to 
maintain body temperature between 37 ° and 40 ° C. Intu- 
bation of the trachea was done with a 14-gauge, 21/4-inch 
plastic intravenous cannula (Becton Dickinson & Co., 
Sandy, Utah); the animals were supported with positive- 
pressure ventilation (Harvard Rodent Ventilator model 
No. 683, Harvard Apparatus, Co. Inc., Southnatick, 
Mass.) with room air. Indwelling heparinized polyethylene 
catheters (PE 50, Clay Adams, Parsippany, N.J.) were 
placed in the right internal jugular vein for infusion of 
ttuids (Harvard Infusion pump model No. 600-900, Har- 
vard Apparatus Co., Inc., Dover, Mass.) and in the left 
carotid artery for blood sampling and measurement of
blood pressure and heart rate (Datamedix Guardian 
model No. GN 1001, Datamedix, Sharon, Mass.). All 
blood samples were replaced with equal volumes of fresh 
donor blood obtained from normal anesthetized rats via 
abdominal aortic cannulation. Polyethylene (PE 50) tub- 
ing was placed into the bladder via a suprapubic ystos- 
tomy and urine was collected into the modified barrel of a 
1 ml syringe. 
Surgical procedures. The animals were assigned by use 
of a random numbers table into the experimental groups. 
All animals underwent a median sternotomy. Group I was 
the sham control group. After reflection of the pericar- 
dium, there was no manipulation of the atria in four sham 
rats (subgroup IA) and atrial manipulation without injury 
in four other sham rats (subgroup Iß). In both sham 
subgroups, the atrial appendages were left intact. The 
chest was then covered with gauze soaked in isotonic 
saline solution. During the 30-minute recovery period that 
followed the operation, a continuous infusion of isotonic 
saline was administered at a rate of 20/A/min. After the 
recovery period, a fluid challenge with isotonic saline 
solution in a volume equivalent to 1% body weight was 
given over 30 minutes. Blood samples and urine output 
were measured at 15, 30, and 45 minutes after the fluid 
challenge. A maintenance infusion at a rate of 20 ~l/min 
of isotonic saline solution was started after the fluid 
challenge and was maintained for the duration of the 
experiment. 
In group II (n = 8), after sternotomy and reflection of 
the pericardium, both atrial appendages were gently re- 
tracted to their maximum length; 5-0 silk ligatures (Ethi- 
con, Inc., Somerville, N.J.) were placed at the base of each 
appendage after which atrial appendectomy was per- 
formed. As in group I, a fluid challenge was followed by a 
maintenance infusion. 
In group III (n = 18), the identical surgical protocol 
used with the group II animals was followed with the 
exception that at the end of the fluid challenge, a contin- 
uous infusion of atriopeptin III, M.W. 2550, at 20/xl/min 
was maintained until completion of the experiment. The 
Table I. Results 30 minutes after infusion: sham 
groups lA and Iß 
Group lA: Group Iß: 
no manipulation manipulation 
ANP levels 172.8 _+ 51.9 122.5 + 144.9 
(prnol/min) 
Urine output 0.15 _+ 0.05 0.18 + 0.05 
(ml/15 min) 
Heart rate 382.5 _+ 39.9 360 _+ 39.9 
(beats/min) 
Systolic BP 113.7 _+ 11.9 104.8 _+ 10.3 
(mm Hg) 
All results are expressed as mean + standard error of mean. BP, Blood 
pressure. 
concentration of the natriuretic peptide was varied in five 
subgroups (subgroups A through E: 0.5, 5, 25, 50, and 100 
pmol/min, respectively), but the infusion volume was 
maintained at 20/A/min. 
Blood samples and assay. Blood samples were drawn 
from the carotid artery catheter in 1 ml aliquots for ANP 
determination at 15, 30, and 45 minutes after completion 
of the fluid challenge. The blood samples were added to 
vacuum blood collection tubes (Terumo Medical, Elkton, 
Md.) that contained 0.05 ml of 15% liquid ethylenediami- 
netetraacetic a id and 10 KIU aprotinin (Sigma, St. Louis, 
Mo.). The samples were kept on ice until the end of the 
experiment. The tubes were centrifuged at 3500 rpm for 5 
minutes and the separated plasma was stored in polypro- 
pylene tubes in a liquid nitrogen refrigerator at -196 ° C 
until the time of extraction. 27 Each sample was coded to 
prevent identification at the time of assay. 
ANP levels were determined by the use of the radioim- 
munoassay disequilibrium technique method outlined by 
Stewart and associates. 28The minimal concentration of 
ANP 99 to 126 amino acids detected ranged from 0.5 to 
1.0 pg/ml. Intraassay variability was 4%, and interassay 
variability was 8%. Percent extraction was 74% +_ 3%. 
Statistieal analysis. Data between groups were ana- 
lyzed by an analysis of variance. Post hoc evaluation was 
done with the Scheffe test. Statistically significant differ- 
ence was determined atp --- 0.05. The mean plus or minus 
the standard error of the mean are reported. 
Results 
Results were compared at all time points and 
between all groups; however, only the results that 
represented the maximum effect (30 minutes after 
the end of the fluid ¢hallenge) and the 5 pmol/min 
dose of  ANP data are presented. Because there was 
no significant difference in urine output, ANP levels, 
heart rates, or blood pressure 30 minutes after a 
fluid challenge between the subgroups of sham rats 
(Table I), the data of these subgroups have been 
pooled and are presented in Table II. 
Biatrial appendectomies (group II) resulted in the 
lowest urine output, which was statistically signifi- 
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Fig. 1. Urine output (UOP) expressed in milliliters per 15 minutes. BAA, Biatrial appendectomy; ANP,
atrial natriuretic peptide. Doses are in picomoles per minute. Urine outputs for sham and ANP infusion 
groups are significantly different from those f group II (p -< 0.01) at all times. 
Table II. Results 30 minutes after fluid challenge 
Experimental group ANP levels Systolic BP Heart rate 
Sham 
Group I 146.9 + 87.1 108.6 _+ 14 371.3 + 19 
BAA 
Group II 22.9 _+ 10.8 109.5 _+ 13 420 _+ 20 
ANP 0.5 pmol/min 
Group I I IA 33.8 + 9.7 120 _+ 9 397.5 _+ 33 
ANP 5.0 pmol/min 
Group IIIB 187.8 _+ 43.3 111 + 8 375 _+ 29 
ANP 25 pmol/min 
Group IIIC 652.3 _+ 146.6 103.7 __ 6 412.5 _+ i1 
ANP 50 pmol/min 
Group II ID 1713 _+ 603.8 97.3 _+ 8 480 
ANP 100 pmol/min 
Group I I IE 2292 _+ 768.9 98.7 _+ 6 375 _+ 26 
All results are expressed as mean _+ st dard error of mean. All ANP 
levels are significantly different from those in group II (p -< 0.01); there is 
no significant difference in blood pressure or heart rate. BAd, Biatrial 
appendectomy; BP, mean systolic blood pressure. ANP levels are ex- 
pressed in picograms per milliliter. 
cant when compared with that of all other animals 
(p -< 0.01; Fig. 1). Additionally, group II rats had the 
lowest ANP levels when compared with those of all 
other animals (p _< 0.01; Table II). 
After biatrial appendectomies, xogenous admin- 
istration of ANP (group III) resulted in an incre- 
mental increase in urine output, with peak urine 
outputs occurring at an infusion concentration f 50 
pmol/min (subgroup IIID) and at a time interval 
between 15 and 30 minutes of infusion. Infusion of 
ANP at 0.5 pmol/min (group IIIA) resulted in urine 
output and ANP levels significantly higher than 
those of group II (Table II and Fig. 1; p -< 0.01). 
Serum levels of ANP increased correspondingly up
to an infusion rate of 100 pmol/min (Table II). 
The heart rate and blood pressure did not vary 
significantly between groups. 
Discussion 
On the basis of the results of prior series of 
studies that demonstrated that loss of the right atrial 
appendage may cause fluid retention and, second, 
that exogenous ANP can induce diuresis, we postu- 
lated that use of exogenous ANP could reverse the 
antidiuresis noted in some patients after the Cox 
maze procedure despite good ventricular func- 
tion. 1'2 Among the possible causes of the fluid 
retention isANP depletion secondary to the multi- 
ple atrial incisions and biatrial appendectomies. 1, 2 
Clinical postoperative studies have documented 
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ANP depletion after right atrial or biatrial appen- 
dectomies and significantly higher levels of ANP and 
bettet diuresis and natriuresis after volume expan- 
sion in patients in whom the right atrial appendage 
was preserved uring venous cannulation. » In regard 
to the Cox maze procedure, we could not find any 
prior documentation of postoperative ANP levels, 
although Cox and associates 1 postulated that atten- 
uated serum ANP levels may contribute to postop- 
erative fluid retention. 
In previous studies on rats and dogs, in which 
biatrial appendectomies (but not left atrial appen- 
dectomy alone) were done, diuresis and natriuresis 
were blunted in response to a fluid challenge. 22-25 In 
our study, we did biatrial appendectomies to simu- 
late that portion of the maze procedure. We dem- 
onstrated a blunted diuretic response and low ANP 
levels in group II (biatrial appendectomies), 
whereas in the sham group a brisk diuresis was 
noted. With the use of varying concentrations of
ANP, diuresis was restored in animals who under- 
went the same surgical procedure as the animals in 
group II, which supports our hypothesis. The use of 
low-dose ANP is important because the side effects 
in human subjects reported appear to be dose 
related.13-15, 17
Cody, Atlas, and Laragh 15 reviewed the studies 
done on human subjects who received synthetic 
preparations of ANP. The majority of those studied 
fell into two major categories: normal control sub- 
jects and those with fluid overload states. It was 
noted that a significant diuretic response was elic- 
ited in a group of healthy subjects with normal ANP 
levels. Also noted was a blunted response to ANP 
infusions in patients with congestive heart failure, 
who have high endogenous ANP levels. 19'29 The 
attenuated response to exogenous ANP may be due 
to diminished renal perfusion in congestive heart 
failure 29-31 or saturation of ANP binding sites. The 
fluid retention seen after the maze procedure and 
other cardiac procedures that damage the atrial 
appendages is not caused by the same mechanism as 
that in clinical congestive heart failure caused by 
poor ventricular function. Therefore exogenous 
ANP may have an important clinical application in 
postoperative olume overload states. We could not 
locate a study in which exogenous ANP was admin- 
istered after heart operations or in patients with 
diminished ANP levels. 
Side effects with ANP administration include 
bradycardia and hypotension. 12' 13, 18, 19 Cody, Atlas, 
and Laragh 15 reported that with steady-state ANP 
administration i normal supine subjects, no signiß 
icant change in blood pressure was noted. In our 
study, there was no change in heart rate or blood 
pressure in rats as the dose of ANP increased up to 100 
pg/min (Table II). Although natriuresis has been noted 
with exogenous ANP infusion, serum electrolyte ab- 
normalities have not been noted. 13' 14, 32, 33 
After biatrial appendectomies, exogenous ANP 
reversed the surgically created antidiuresis in rats. 
Exogenous ANP may offer an alternative therapy 
for the fluid retention seen in some patients under- 
going the Cox maze procedure that may result from 
the atrial appendectomies and multiple atrial inci- 
sions. The effects of the maze III modifications in 
eliminating the problem of postoperative fluid re- 
tention seen in some patients after the original maze 
procedure is not known. The information generated 
by the dose-response curve may aid in the determi- 
nation of the appropriate dosage for clinical use. 
We thank Miguel Torres for his technical assistance. 
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